Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
35
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Dillman John Robert | Chief Commercial Officer | 3 | $0 | $0 | 2023-07-27 |
| Braga Damian | Director | 5 | $0 | $0 | 2023-07-27 |
| Cordeiro Joanne | Director | 6 | $0 | $0 | 2023-07-27 |
| Mazaltov Avi | Head Global MFG&GM-SciVac Ltd. | 10 | $0 | $0 | 2023-07-27 |
| Beattie Nell | Director, Corp Development/IR | 20 | $34.8K | $0 | 2023-07-27 |
| Diaz-Mitoma Francisco | Chief Medical Officer | 21 | $140.2K | $0 | 2023-07-27 |
| McKee Blaine H. | Director | 6 | $0 | $0 | 2023-07-27 |
| Anderson David Evander | Senior VP, Researc | 20 | $0 | $0 | 2023-07-27 |
| Baxter Jeff | Chief Executive Officer | 30 | $489.8K | $0 | 2023-07-27 |
| DeWilde Michel | Director | 16 | $0 | $0 | 2023-07-27 |
| HIMES VAUGHN B | Director | 2 | $0 | $0 | 2023-07-27 |
| GILLIS STEVEN | Director, 10% Owner | 22 | $6.92M | $0 | 2023-07-27 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 17 | $66.41M | $7.17M | 2023-04-06 |
| McNulty Christopher | CFO and Head of BD | 9 | $5.6K | $0 | 2023-01-26 |
| Bain Linda | Director | 2 | $0 | $0 | 2022-01-27 |
| EDELMAN JOSEPH | 10% Owner | 4 | $16.33M | $8.96M | 2021-12-01 |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 10% Owner | 4 | $2.00M | $2.46M | 2021-06-29 |
| Requadt Scott | Director | 7 | $0 | $0 | 2019-01-31 |
| Kariv Tomer | Director | 6 | $2.00M | $0 | 2019-01-31 |
| Rubin Steven D | Director | 6 | $0 | $0 | 2018-06-14 |
| Logal Adam | Director | 6 | $0 | $0 | 2018-06-14 |
| Kartsaklis Athena | SVP Finance, CCO | 1 | $0 | $0 | 2018-01-23 |
| Buckley T. Adam | VP, Business Development | 5 | $0 | $0 | 2018-01-23 |
| Opko Health, Inc. | 10% Owner | 1 | $2.00M | $0 | 2017-10-30 |
| CHAWLA SAM | Director | 5 | $9.46M | $0 | 2017-10-30 |
| Eckenswiller Catherine | Contracts and IP Counsel | 1 | $0 | $0 | 2017-03-31 |
| Nascimento Egidio | Chief Financial Officer | 2 | $0 | $0 | 2017-03-30 |
| NELSEN ROBERT | 10% Owner | 1 | $0 | $0 | 2015-08-13 |
| Kirchmeier Marc | VP, Vaccine Form Development | 1 | $0 | $0 | 2015-07-30 |
| TIMMINS ALAN P | Director | 2 | $0 | $0 | 2015-07-30 |
| DAVIS TRENT D | Director | 6 | $0 | $0 | 2015-07-30 |
| STEINMETZ MICHAEL | Director | 1 | $0 | $0 | 2015-07-30 |
| SHOEN PAUL F | Other | 2 | $0 | $0 | 2014-07-25 |
| PAULSON CHARLES | Other | 3 | $0 | $0 | 2014-07-25 |
| Smith Murray George | Other | 1 | $0 | $0 | 2014-07-25 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Cordeiro Joanne | Director | A Award deriv | 2023-07-27 | 2023-07-28 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Baxter Jeff | CEO, President | A Award deriv | 2023-07-27 | 2023-07-28 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Beattie Nell | CFO, Head of Corp. Developme | A Award deriv | 2023-07-27 | 2023-07-28 | 52,500 | — | $0 | 52,500 | SEC↗ |
| HIMES VAUGHN B | Director | A Award deriv | 2023-07-27 | 2023-07-28 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | A Award deriv | 2023-07-27 | 2023-07-28 | 52,500 | — | $0 | 52,500 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | A Award deriv | 2023-07-27 | 2023-07-28 | 52,500 | — | $0 | 52,500 | SEC↗ |
| McKee Blaine H. | Director | A Award deriv | 2023-07-27 | 2023-07-28 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GILLIS STEVEN | Director | A Award deriv | 2023-07-27 | 2023-07-28 | 52,500 | — | $0 | 52,500 | SEC↗ |
| Dillman John Robert | Chief Commercial Officer | A Award deriv | 2023-07-27 | 2023-07-28 | 52,500 | — | $0 | 52,500 | SEC↗ |
| Mazaltov Avi | Head Global MFG&GM-SciVac Lt | A Award deriv | 2023-07-27 | 2023-07-28 | 52,500 | — | $0 | 52,500 | SEC↗ |
| DeWilde Michel | Director | A Award deriv | 2023-07-27 | 2023-07-31 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Braga Damian | Director | A Award deriv | 2023-07-27 | 2023-07-31 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GILLIS STEVEN | Director | P Buy deriv | 2023-07-10 | 2023-07-18 | 609,090 | — | $0 | 609,090 | SEC↗ |
| GILLIS STEVEN | Director | P Buy | 2023-07-10 | 2023-07-18 | 609,090 | $1.65 | $1.00M | 1,043,292 | SEC↗ |
| HIMES VAUGHN B | Director | A Award deriv | 2023-04-27 | 2023-04-28 | 8,000 | — | $0 | 8,000 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | 10% Owner | S Sale | 2023-04-06 | 2023-04-06 | 4,251,563 | $0.11 | $467.7K | 41,440,729 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | 10% Owner | S Sale | 2023-04-05 | 2023-04-06 | 1,832,563 | $0.13 | $238.2K | 45,691,816 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | 10% Owner | S Sale | 2023-04-04 | 2023-04-06 | 4,810,623 | $0.16 | $769.7K | 47,524,379 | SEC↗ |
| McKee Blaine H. | Director | A Award deriv | 2023-01-26 | 2023-01-30 | 50,000 | — | $0 | 50,000 | SEC↗ |
| McNulty Christopher | CFO and Head of BD | A Award deriv | 2023-01-26 | 2023-01-30 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Beattie Nell | Chief Business Officer | A Award deriv | 2023-01-26 | 2023-01-30 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | A Award deriv | 2023-01-26 | 2023-01-30 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | A Award deriv | 2023-01-26 | 2023-01-30 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Braga Damian | Director | A Award deriv | 2023-01-26 | 2023-01-30 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Baxter Jeff | CEO, President | A Award deriv | 2023-01-26 | 2023-01-30 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Dillman John Robert | Chief Commercial Officer | A Award deriv | 2023-01-26 | 2023-01-30 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Cordeiro Joanne | Director | A Award deriv | 2023-01-26 | 2023-01-30 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GILLIS STEVEN | Director | A Award deriv | 2023-01-26 | 2023-01-30 | 75,000 | — | $0 | 75,000 | SEC↗ |
| DeWilde Michel | Director | A Award deriv | 2023-01-26 | 2023-01-30 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Mazaltov Avi | Head Global MFG&GM-SciVac Lt | A Award deriv | 2023-01-26 | 2023-01-30 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Dillman John Robert | Chief Commercial Officer | A Award deriv | 2022-07-07 | 2022-07-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | A Award deriv | 2022-01-27 | 2022-01-31 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Bain Linda | Director | A Award deriv | 2022-01-27 | 2022-01-31 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Baxter Jeff | CEO, President | A Award deriv | 2022-01-27 | 2022-01-31 | 800,000 | — | $0 | 800,000 | SEC↗ |
| Beattie Nell | Chief Business Officer | A Award deriv | 2022-01-27 | 2022-01-31 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Braga Damian | Director | A Award deriv | 2022-01-27 | 2022-01-31 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Cordeiro Joanne | Director | A Award deriv | 2022-01-27 | 2022-01-31 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | A Award deriv | 2022-01-27 | 2022-01-31 | 400,000 | — | $0 | 400,000 | SEC↗ |
| GILLIS STEVEN | Director | A Award deriv | 2022-01-27 | 2022-01-31 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Mazaltov Avi | Head Global MFG&GM-SciVac Lt | A Award deriv | 2022-01-27 | 2022-01-31 | 400,000 | — | $0 | 400,000 | SEC↗ |
| McKee Blaine H. | Director | A Award deriv | 2022-01-27 | 2022-01-31 | 75,000 | — | $0 | 75,000 | SEC↗ |
| McNulty Christopher | CFO and Head of BD | A Award deriv | 2022-01-27 | 2022-01-31 | 400,000 | — | $0 | 400,000 | SEC↗ |
| DeWilde Michel | Director | A Award deriv | 2022-01-27 | 2022-01-31 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Beattie Nell | Chief Business Officer | P Buy | 2021-12-03 | 2021-12-06 | 8,200 | $2.45 | $20.1K | 68,200 | SEC↗ |
| EDELMAN JOSEPH | 10% Owner | S Sale | 2021-12-01 | 2021-12-03 | 2,707,463 | $3.31 | $8.96M | 52,334,993 | SEC↗ |
| Bain Linda | Director | A Award deriv | 2021-07-01 | 2021-07-07 | 250,000 | — | $0 | 250,000 | SEC↗ |
| PERCEPTIVE LIFE SCIENCES MASTE | 10% Owner | S Sale | 2021-06-29 | 2021-06-30 | 500,709 | $3.80 | $1.90M | 0 | SEC↗ |
| PERCEPTIVE LIFE SCIENCES MASTE | 10% Owner | S Sale | 2021-06-29 | 2021-06-30 | 145,548 | $3.80 | $553.1K | 0 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | 10% Owner | X Exercise deriv | 2021-06-09 | 2021-06-11 | 1,602,888 | — | $0 | 0 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | 10% Owner | X Exercise deriv | 2021-06-09 | 2021-06-11 | 465,936 | — | $0 | 0 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | 10% Owner | X Exercise | 2021-06-09 | 2021-06-11 | 465,936 | $2.75 | $1.28M | 465,936 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | 10% Owner | S Sale | 2021-06-09 | 2021-06-11 | 1,102,179 | $4.00 | $4.41M | 500,709 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | 10% Owner | S Sale | 2021-06-09 | 2021-06-11 | 320,388 | $4.00 | $1.28M | 145,548 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | 10% Owner | X Exercise | 2021-06-09 | 2021-06-11 | 1,602,888 | $2.75 | $4.41M | 1,602,888 | SEC↗ |
| CEO, President | A Award deriv | 2021-01-27 | 2021-01-29 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ | |
| GILLIS STEVEN | Director | A Award deriv | 2021-01-27 | 2021-01-29 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | A Award deriv | 2021-01-27 | 2021-01-29 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Cordeiro Joanne | Director | A Award deriv | 2021-01-27 | 2021-01-29 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CFO and Head of BD | A Award deriv | 2021-01-27 | 2021-01-29 | 500,000 | — | $0 | 500,000 | SEC↗ | |
| Beattie Nell | Chief Business Officer | A Award deriv | 2021-01-27 | 2021-01-29 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Braga Damian | Director | A Award deriv | 2021-01-27 | 2021-01-29 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | A Award deriv | 2021-01-27 | 2021-01-29 | 500,000 | — | $0 | 500,000 | SEC↗ |
| McKee Blaine H. | Director | A Award deriv | 2021-01-27 | 2021-01-29 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Mazaltov Avi | Head Global MFG&GM-SciVac Lt | A Award deriv | 2021-01-27 | 2021-02-01 | 500,000 | — | $0 | 500,000 | SEC↗ |
| DeWilde Michel | Director | A Award deriv | 2021-01-27 | 2021-02-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| McNulty Christopher | CFO and Head of BD | A Award deriv | 2020-07-01 | 2020-07-02 | 170,100 | — | $0 | 170,100 | SEC↗ |
| Beattie Nell | Chief Business Officer | A Award deriv | 2020-07-01 | 2020-07-02 | 170,100 | — | $0 | 170,100 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | A Award deriv | 2020-07-01 | 2020-07-02 | 170,100 | — | $0 | 170,100 | SEC↗ |
| Baxter Jeff | CEO, President | A Award deriv | 2020-07-01 | 2020-07-02 | 425,200 | — | $0 | 425,200 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | A Award deriv | 2020-07-01 | 2020-07-02 | 167,150 | — | $0 | 167,150 | SEC↗ |
| Mazaltov Avi | Head Global MFG&GM-SciVac Lt | A Award deriv | 2020-07-01 | 2020-07-02 | 167,150 | — | $0 | 167,150 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | 10% Owner | P Buy | 2020-04-24 | 2020-04-28 | 9,090,909 | $1.10 | $10.00M | 55,042,456 | SEC↗ |
| Braga Damian | Director | A Award deriv | 2020-03-24 | 2020-03-24 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Beattie Nell | Chief Business Officer | A Award deriv | 2020-01-22 | 2020-01-24 | 350,000 | — | $0 | 350,000 | SEC↗ |
| DeWilde Michel | Director | A Award deriv | 2020-01-22 | 2020-01-24 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Baxter Jeff | CEO, President | A Award deriv | 2020-01-22 | 2020-01-24 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Cordeiro Joanne | Director | A Award deriv | 2020-01-22 | 2020-01-24 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | A Award deriv | 2020-01-22 | 2020-01-24 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | A Award deriv | 2020-01-22 | 2020-01-24 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Mazaltov Avi | Head Global MFG&GM-SciVac Lt | A Award deriv | 2020-01-22 | 2020-01-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| McKee Blaine H. | Director | A Award deriv | 2020-01-22 | 2020-01-24 | 250,000 | — | $0 | 250,000 | SEC↗ |
| GILLIS STEVEN | Director | A Award deriv | 2020-01-22 | 2020-01-24 | 350,000 | — | $0 | 350,000 | SEC↗ |
| McNulty Christopher | CFO and Head of BD | A Award deriv | 2020-01-22 | 2020-01-24 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | P Buy | 2019-10-04 | 2019-10-07 | 40,000 | $0.50 | $20.0K | 117,500 | SEC↗ |
| Beattie Nell | Chief Business Officer | P Buy | 2019-10-01 | 2019-10-01 | 10,000 | $0.48 | $4.8K | 60,000 | SEC↗ |
| McNulty Christopher | CFO and Head of BD | P Buy | 2019-10-01 | 2019-10-01 | 12,000 | $0.47 | $5.6K | 37,000 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | P Buy | 2019-09-30 | 2019-10-07 | 14,500 | $0.50 | $7.3K | 14,500 | SEC↗ |
| Baxter Jeff | CEO, President | P Buy | 2019-09-30 | 2019-09-30 | 150,000 | $0.50 | $75.0K | 608,255 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | 10% Owner | P Buy | 2019-09-23 | 2019-09-24 | 20,000,000 | $0.50 | $10.00M | 45,951,556 | SEC↗ |
| GILLIS STEVEN | Director | P Buy | 2019-09-19 | 2019-09-23 | 10,000,000 | $0.50 | $5.00M | 13,026,057 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | P Buy | 2019-06-27 | 2019-07-01 | 8,000 | $1.07 | $8.6K | 77,500 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | P Buy | 2019-06-20 | 2019-06-20 | 42,000 | $0.89 | $37.4K | 69,500 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | P Buy | 2019-06-20 | 2019-06-20 | 10,000 | $0.78 | $7.8K | 27,500 | SEC↗ |
| Baxter Jeff | CEO, President | P Buy | 2019-06-19 | 2019-06-19 | 144,000 | $0.73 | $105.1K | 458,255 | SEC↗ |
| Beattie Nell | Chief Business Officer | P Buy | 2019-06-19 | 2019-06-19 | 8,000 | $0.74 | $5.9K | 50,000 | SEC↗ |
| PERCEPTIVE LIFE SCIENCES MASTE | 10% Owner | P Buy | 2019-06-18 | 2019-06-20 | 1,000,000 | $0.65 | $650.0K | 25,951,556 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | 10% Owner | P Buy | 2019-06-17 | 2019-06-18 | 1,000,000 | $0.62 | $620.0K | 24,951,556 | SEC↗ |
| Beattie Nell | Chief Business Officer | M Exercise deriv | 2019-06-14 | 2019-06-18 | 6,250 | — | $0 | 0 | SEC↗ |
| DeWilde Michel | Director | M Exercise deriv | 2019-06-14 | 2019-06-18 | 12,500 | — | $0 | 0 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | M Exercise deriv | 2019-06-14 | 2019-06-18 | 21,875 | — | $0 | 0 | SEC↗ |
| GILLIS STEVEN | Director | M Exercise deriv | 2019-06-14 | 2019-06-18 | 18,750 | — | $0 | 0 | SEC↗ |
| Baxter Jeff | CEO, President | M Exercise deriv | 2019-06-14 | 2019-06-18 | 31,250 | — | $0 | 0 | SEC↗ |
| Beattie Nell | Chief Business Officer | M Exercise | 2019-06-14 | 2019-06-18 | 6,250 | — | $0 | 42,000 | SEC↗ |
| DeWilde Michel | Director | M Exercise | 2019-06-14 | 2019-06-18 | 12,500 | — | $0 | 50,000 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | M Exercise | 2019-06-14 | 2019-06-18 | 21,875 | — | $0 | 148,209 | SEC↗ |
| GILLIS STEVEN | Director | M Exercise | 2019-06-14 | 2019-06-18 | 18,750 | — | $0 | 84,416 | SEC↗ |
| Baxter Jeff | CEO, President | M Exercise | 2019-06-14 | 2019-06-18 | 31,250 | — | $0 | 314,255 | SEC↗ |
| Cordeiro Joanne | Director | A Award deriv | 2019-04-18 | 2019-04-24 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Beattie Nell | Chief Business Officer | A Award deriv | 2019-01-31 | 2019-02-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | A Award deriv | 2019-01-31 | 2019-02-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Requadt Scott | Director | A Award deriv | 2019-01-31 | 2019-02-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| McNulty Christopher | CFO and Head of BD | A Award deriv | 2019-01-31 | 2019-02-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| DeWilde Michel | Director | A Award deriv | 2019-01-31 | 2019-02-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Baxter Jeff | CEO, President | A Award deriv | 2019-01-31 | 2019-02-04 | 450,000 | — | $0 | 450,000 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | A Award deriv | 2019-01-31 | 2019-02-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| GILLIS STEVEN | Director | A Award deriv | 2019-01-31 | 2019-02-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| McKee Blaine H. | Director | A Award deriv | 2019-01-31 | 2019-02-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Kariv Tomer | Director | A Award deriv | 2019-01-31 | 2019-02-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Beattie Nell | Chief Business Officer | A Award | 2019-01-31 | 2019-02-04 | 15,000 | — | $0 | 35,750 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | A Award | 2019-01-31 | 2019-02-04 | 25,000 | — | $0 | 126,334 | SEC↗ |
| Mazaltov Avi | Head Global MFG&GM-SciVac Lt | A Award | 2019-01-31 | 2019-02-04 | 90,000 | — | $0 | 196,000 | SEC↗ |
| McNulty Christopher | CFO and Head of BD | A Award | 2019-01-31 | 2019-02-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Baxter Jeff | CEO, President | A Award | 2019-01-31 | 2019-02-04 | 50,000 | — | $0 | 283,005 | SEC↗ |
| Kariv Tomer | Director | P Buy | 2018-12-17 | 2018-12-18 | 612,997 | $1.40 | $858.2K | 1,744,969 | SEC↗ |
| Kariv Tomer | Director | P Buy | 2018-12-17 | 2018-12-18 | 298,431 | $1.40 | $417.8K | 849,520 | SEC↗ |
| Kariv Tomer | Director | P Buy | 2018-12-17 | 2018-12-18 | 185,714 | $1.40 | $260.0K | 185,714 | SEC↗ |
| Kariv Tomer | Director | P Buy | 2018-12-17 | 2018-12-18 | 331,429 | $1.40 | $464.0K | 943,451 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | 10% Owner | P Buy | 2018-12-13 | 2018-12-17 | 14,285,714 | $1.40 | $20.00M | 23,631,439 | SEC↗ |
| McNulty Christopher | CFO and Head of BD | A Award deriv | 2018-09-19 | 2018-09-21 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Baxter Jeff | CEO, President | P Buy | 2018-08-06 | 2018-08-07 | 8,100 | $1.93 | $15.6K | 233,005 | SEC↗ |
| Beattie Nell | Chief Business Officer | P Buy | 2018-08-03 | 2018-08-03 | 2,000 | $2.01 | $4.0K | 20,750 | SEC↗ |
| Baxter Jeff | CEO, President | P Buy | 2018-08-03 | 2018-08-06 | 13,500 | $2.01 | $27.1K | 224,905 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | P Buy | 2018-08-03 | 2018-08-06 | 6,000 | $2.10 | $12.6K | 17,500 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | P Buy | 2018-08-02 | 2018-08-06 | 3,000 | $2.20 | $6.6K | 11,500 | SEC↗ |
| Baxter Jeff | CEO, President | P Buy | 2018-07-31 | 2018-08-01 | 16,800 | $2.28 | $38.3K | 211,405 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | F Tax w/h | 2018-06-14 | 2018-07-03 | 9,281 | $3.76 | $34.9K | 101,334 | SEC↗ |
| Baxter Jeff | CEO, President | M Exercise deriv | 2018-06-14 | 2018-06-18 | 31,250 | — | $0 | 31,250 | SEC↗ |
| Beattie Nell | Chief Business Officer | M Exercise deriv | 2018-06-14 | 2018-06-18 | 6,250 | — | $0 | 6,250 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | M Exercise deriv | 2018-06-14 | 2018-06-18 | 21,875 | — | $0 | 21,875 | SEC↗ |
| Logal Adam | Director | M Exercise deriv | 2018-06-14 | 2018-06-18 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Requadt Scott | Director | M Exercise deriv | 2018-06-14 | 2018-06-18 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Rubin Steven D | Director | M Exercise deriv | 2018-06-14 | 2018-06-18 | 18,750 | — | $0 | 18,750 | SEC↗ |
| DeWilde Michel | Director | M Exercise deriv | 2018-06-14 | 2018-06-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| GILLIS STEVEN | Director | M Exercise deriv | 2018-06-14 | 2018-06-25 | 18,750 | — | $0 | 18,750 | SEC↗ |
| Baxter Jeff | CEO, President | M Exercise | 2018-06-14 | 2018-06-18 | 31,250 | — | $0 | 194,605 | SEC↗ |
| Beattie Nell | Chief Business Officer | M Exercise | 2018-06-14 | 2018-06-18 | 6,250 | — | $0 | 18,750 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | F Tax w/h | 2018-06-14 | 2018-06-18 | 9,306 | $3.76 | $35.0K | 101,309 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | M Exercise | 2018-06-14 | 2018-06-18 | 21,875 | — | $0 | 110,615 | SEC↗ |
| Logal Adam | Director | M Exercise | 2018-06-14 | 2018-06-18 | 12,500 | — | $0 | 37,500 | SEC↗ |
| Requadt Scott | Director | M Exercise | 2018-06-14 | 2018-06-18 | 12,500 | — | $0 | 37,500 | SEC↗ |
| Rubin Steven D | Director | M Exercise | 2018-06-14 | 2018-06-18 | 18,750 | — | $0 | 56,250 | SEC↗ |
| DeWilde Michel | Director | M Exercise | 2018-06-14 | 2018-06-20 | 12,500 | — | $0 | 37,500 | SEC↗ |
| GILLIS STEVEN | Director | M Exercise | 2018-06-14 | 2018-06-25 | 18,750 | — | $0 | 65,666 | SEC↗ |
| Baxter Jeff | CEO, President | P Buy | 2018-05-24 | 2018-05-25 | 11,000 | $2.99 | $32.9K | 163,355 | SEC↗ |
| Baxter Jeff | CEO, President | P Buy | 2018-05-11 | 2018-05-14 | 7,100 | $2.91 | $20.7K | 152,355 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | P Buy | 2018-05-11 | 2018-05-14 | 4,500 | $3.13 | $14.1K | 268,839 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | P Buy | 2018-05-11 | 2018-05-14 | 5,500 | $2.98 | $16.4K | 8,500 | SEC↗ |
| Mazaltov Avi | Head Global MFG&GM-SciVac Lt | A Award deriv | 2018-01-23 | 2018-06-29 | 0 | — | $0 | 0 | SEC↗ |
| Mazaltov Avi | Head Global MFG&GM-SciVac Lt | A Award | 2018-01-23 | 2018-06-29 | 100,000 | — | $0 | 106,000 | SEC↗ |
| Baxter Jeff | CEO, President | A Award deriv | 2018-01-23 | 2018-01-25 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Beattie Nell | Chief Business Officer | A Award deriv | 2018-01-23 | 2018-01-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | A Award deriv | 2018-01-23 | 2018-01-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Buckley T. Adam | VP, Business Development | A Award deriv | 2018-01-23 | 2018-01-25 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Requadt Scott | Director | A Award deriv | 2018-01-23 | 2018-01-25 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Rubin Steven D | Director | A Award deriv | 2018-01-23 | 2018-01-25 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | A Award deriv | 2018-01-23 | 2018-01-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Logal Adam | Director | A Award deriv | 2018-01-23 | 2018-01-25 | 75,000 | — | $0 | 75,000 | SEC↗ |
| GILLIS STEVEN | Director | A Award deriv | 2018-01-23 | 2018-01-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| DeWilde Michel | Director | A Award deriv | 2018-01-23 | 2018-01-26 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Kariv Tomer | Director | A Award deriv | 2018-01-23 | 2018-01-29 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Mazaltov Avi | Head Global MFG&GM-SciVac Lt | A Award deriv | 2018-01-23 | 2018-01-30 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Kartsaklis Athena | SVP Finance, CCO | A Award deriv | 2018-01-23 | 2018-02-06 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Baxter Jeff | CEO, President | P Buy | 2017-12-12 | 2017-12-13 | 4,609 | $3.88 | $17.9K | 145,255 | SEC↗ |
| Baxter Jeff | CEO, President | P Buy | 2017-12-12 | 2017-12-13 | 5,391 | $3.89 | $21.0K | 140,646 | SEC↗ |
| Baxter Jeff | CEO, President | P Buy | 2017-11-28 | 2017-11-29 | 15,000 | $4.75 | $71.3K | 135,255 | SEC↗ |
| CHAWLA SAM | Director | P Buy | 2017-10-30 | 2017-10-31 | 3,100,000 | $3.05 | $9.46M | 9,345,725 | SEC↗ |
| GILLIS STEVEN | Director | P Buy | 2017-10-30 | 2017-10-31 | 300,000 | $3.05 | $915.0K | 3,026,057 | SEC↗ |
| Opko Health, Inc. | 10% Owner | P Buy | 2017-10-30 | 2017-11-01 | 655,738 | $3.05 | $2.00M | 6,678,752 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | 10% Owner | P Buy | 2017-10-26 | 2017-10-30 | 3,100,000 | $3.05 | $9.46M | 9,345,725 | SEC↗ |
| Baxter Jeff | CEO, President | P Buy | 2017-08-21 | 2017-08-22 | 10,000 | $3.22 | $32.2K | 120,255 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | P Buy | 2017-08-21 | 2017-08-22 | 3,000 | $3.17 | $9.5K | 3,000 | SEC↗ |
| Baxter Jeff | CEO, President | P Buy | 2017-08-10 | 2017-08-14 | 10,000 | $3.28 | $32.8K | 110,255 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | A Award | 2017-06-22 | 2017-06-23 | 12,500 | — | $0 | 264,339 | SEC↗ |
| Logal Adam | Director | M Exercise deriv | 2017-06-14 | 2017-06-16 | 12,500 | — | $0 | 25,000 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | M Exercise deriv | 2017-06-14 | 2017-06-16 | 21,875 | — | $0 | 43,750 | SEC↗ |
| Baxter Jeff | CEO, President | M Exercise deriv | 2017-06-14 | 2017-06-16 | 31,250 | — | $0 | 62,500 | SEC↗ |
| Beattie Nell | DCD | M Exercise deriv | 2017-06-14 | 2017-06-16 | 6,250 | — | $0 | 12,500 | SEC↗ |
| CHAWLA SAM | Director | M Exercise deriv | 2017-06-14 | 2017-06-16 | 12,500 | — | $0 | 25,000 | SEC↗ |
| Requadt Scott | Director | M Exercise deriv | 2017-06-14 | 2017-06-16 | 12,500 | — | $0 | 25,000 | SEC↗ |
| Rubin Steven D | Director | M Exercise deriv | 2017-06-14 | 2017-06-16 | 18,750 | — | $0 | 37,500 | SEC↗ |
| GILLIS STEVEN | Director | M Exercise deriv | 2017-06-14 | 2017-06-16 | 18,750 | — | $0 | 37,500 | SEC↗ |
| Buckley T. Adam | VP, Business Development | M Exercise deriv | 2017-06-14 | 2017-06-16 | 4,687 | — | $0 | 9,374 | SEC↗ |
| DeWilde Michel | Director | M Exercise deriv | 2017-06-14 | 2017-06-16 | 12,500 | — | $0 | 25,000 | SEC↗ |
| Logal Adam | Director | M Exercise | 2017-06-14 | 2017-06-16 | 12,500 | — | $0 | 25,000 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | M Exercise | 2017-06-14 | 2017-06-16 | 21,875 | — | $0 | 88,740 | SEC↗ |
| Baxter Jeff | CEO, President | M Exercise | 2017-06-14 | 2017-06-16 | 31,250 | — | $0 | 100,255 | SEC↗ |
| Beattie Nell | DCD | M Exercise | 2017-06-14 | 2017-06-16 | 6,250 | — | $0 | 12,500 | SEC↗ |
| CHAWLA SAM | Director | M Exercise | 2017-06-14 | 2017-06-16 | 12,500 | — | $0 | 25,000 | SEC↗ |
| Requadt Scott | Director | M Exercise | 2017-06-14 | 2017-06-16 | 12,500 | — | $0 | 25,000 | SEC↗ |
| Rubin Steven D | Director | M Exercise | 2017-06-14 | 2017-06-16 | 18,750 | — | $0 | 37,500 | SEC↗ |
| GILLIS STEVEN | Director | M Exercise | 2017-06-14 | 2017-06-16 | 18,750 | — | $0 | 46,916 | SEC↗ |
| Buckley T. Adam | VP, Business Development | M Exercise | 2017-06-14 | 2017-06-16 | 4,687 | — | $0 | 44,063 | SEC↗ |
| DeWilde Michel | Director | M Exercise | 2017-06-14 | 2017-06-16 | 12,500 | — | $0 | 25,000 | SEC↗ |
| Baxter Jeff | CEO, President | A Award deriv | 2017-04-18 | 2017-04-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Baxter Jeff | CEO, President | A Award deriv | 2017-04-18 | 2017-04-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DeWilde Michel | Director | A Award deriv | 2017-04-17 | 2017-04-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| DeWilde Michel | Director | A Award deriv | 2017-04-17 | 2017-04-27 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Beattie Nell | Director, Corp Development/I | A Award deriv | 2017-04-03 | 2017-04-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | A Award deriv | 2017-03-31 | 2017-04-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Requadt Scott | Director | A Award deriv | 2017-03-31 | 2017-04-04 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Eckenswiller Catherine | Contracts and IP Counsel | A Award deriv | 2017-03-31 | 2017-03-31 | 3,000 | — | $0 | 3,000 | SEC↗ |
| Logal Adam | Director | A Award deriv | 2017-03-30 | 2017-03-31 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CHAWLA SAM | Director | A Award deriv | 2017-03-30 | 2017-03-31 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Nascimento Egidio | Chief Financial Officer | A Award deriv | 2017-03-30 | 2017-03-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Buckley T. Adam | VP, Business Development | A Award deriv | 2017-03-30 | 2017-03-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Rubin Steven D | Director | A Award deriv | 2017-03-30 | 2017-03-31 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | A Award deriv | 2017-03-29 | 2017-03-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GILLIS STEVEN | Director | A Award deriv | 2017-03-29 | 2017-03-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Diaz-Mitoma Francisco | Chief Medical Officer | A Award | 2017-03-29 | 2017-03-31 | 12,500 | — | $0 | 251,839 | SEC↗ |
| GILLIS STEVEN | Director | M Exercise deriv | 2017-01-17 | 2017-03-31 | 6,377 | $2.50 | $15.9K | 0 | SEC↗ |
| GILLIS STEVEN | Director | M Exercise | 2017-01-17 | 2017-03-31 | 6,377 | $2.50 | $15.9K | 28,166 | SEC↗ |
| EDELMAN JOSEPH | 10% Owner | P Buy deriv | 2016-12-06 | 2017-03-09 | 1,341,282 | $3.36 | $4.51M | 2,068,824 | SEC↗ |
| EDELMAN JOSEPH | 10% Owner | P Buy deriv | 2016-12-06 | 2017-03-09 | 363,771 | $4.13 | $1.50M | 727,542 | SEC↗ |
| EDELMAN JOSEPH | 10% Owner | P Buy | 2016-12-06 | 2017-03-09 | 3,383,955 | $3.05 | $10.32M | 6,245,725 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | 10% Owner | P Buy deriv | 2016-12-06 | 2016-12-08 | 1,341,282 | $3.36 | $4.51M | 2,068,824 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | 10% Owner | P Buy deriv | 2016-12-06 | 2016-12-08 | 363,771 | $4.13 | $1.50M | 727,542 | SEC↗ |
| PERCEPTIVE ADVISORS LLC | 10% Owner | P Buy | 2016-12-06 | 2016-12-08 | 3,383,955 | $3.05 | $10.32M | 6,213,314 | SEC↗ |
| PERCEPTIVE LIFE SCIENCES MASTE | 10% Owner | P Buy | 2015-08-14 | 2015-08-18 | 650,000 | $2.08 | $1.35M | 3,260,356 | SEC↗ |
| NELSEN ROBERT | 10% Owner | A Award | 2015-08-13 | 2015-08-17 | 650,000 | $2.10 | $1.36M | 4,047,830 | SEC↗ |
| GILLIS STEVEN | Director, 10% Owner | A Award | 2015-08-13 | 2015-08-17 | 650,000 | $2.10 | $1.36M | 4,047,830 | SEC↗ |
| Buckley T. Adam | VP, Business Development | A Award deriv | 2015-07-30 | 2015-08-05 | 75,000 | — | $0 | 263,926 | SEC↗ |
| Kirchmeier Marc | VP, Vaccine Form Development | A Award deriv | 2015-07-30 | 2015-08-05 | 100,000 | — | $0 | 367,793 | SEC↗ |
| Baxter Jeff | Chief Executive Officer | A Award deriv | 2015-07-30 | 2015-08-05 | 300,000 | — | $0 | 1,344,944 | SEC↗ |
| Anderson David Evander | Chief Scientific Officer | A Award deriv | 2015-07-30 | 2015-08-05 | 225,000 | — | $0 | 682,304 | SEC↗ |
| TIMMINS ALAN P | Director | A Award deriv | 2015-07-30 | 2015-08-05 | 40,000 | — | $0 | 80,000 | SEC↗ |
| Nascimento Egidio | Chief Financial Officer | A Award deriv | 2015-07-30 | 2015-08-05 | 150,000 | — | $0 | 526,700 | SEC↗ |
| STEINMETZ MICHAEL | Director | A Award deriv | 2015-07-30 | 2015-08-05 | 40,000 | — | $0 | 80,000 | SEC↗ |
| DAVIS TRENT D | Director | A Award deriv | 2015-07-30 | 2015-08-05 | 40,000 | — | $0 | 80,000 | SEC↗ |
| DeWilde Michel | Director | A Award deriv | 2015-07-30 | 2015-08-05 | 40,000 | — | $0 | 80,000 | SEC↗ |
| CHAWLA SAM | Director | A Award deriv | 2015-07-30 | 2015-08-05 | 40,000 | — | $0 | 80,000 | SEC↗ |
| GILLIS STEVEN | Director, 10% Owner | A Award deriv | 2015-07-30 | 2015-08-05 | 70,000 | — | $0 | 191,089 | SEC↗ |
| Anderson David Evander | Senior VP, Researc | J Other | 2015-04-08 | 2015-04-10 | 46,731 | — | $0 | 86,787 | SEC↗ |
| DAVIS TRENT D | Director | A Award deriv | 2014-07-25 | 2015-04-02 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PAULSON CHARLES | Other | D To issuer deriv | 2014-07-25 | 2014-07-29 | 7,667 | — | $0 | 0 | SEC↗ |
| SHOEN PAUL F | Other | D To issuer deriv | 2014-07-25 | 2014-07-29 | 5,000 | — | $0 | 0 | SEC↗ |
| DAVIS TRENT D | Director | D To issuer deriv | 2014-07-25 | 2014-07-29 | 3,000 | — | $0 | 0 | SEC↗ |
| PAULSON CHARLES | Other | D To issuer deriv | 2014-07-25 | 2014-07-29 | 7,667 | — | $0 | 0 | SEC↗ |
| DAVIS TRENT D | Director | A Award deriv | 2014-07-25 | 2014-08-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TIMMINS ALAN P | Director | A Award deriv | 2014-07-25 | 2014-08-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PAULSON CHARLES | Other | A Award | 2014-07-25 | 2014-07-29 | 4,260 | — | $0 | 34,260 | SEC↗ |
| SHOEN PAUL F | Other | A Award | 2014-07-25 | 2014-07-29 | 2,778 | — | $0 | 44,155 | SEC↗ |
| DAVIS TRENT D | Director | A Award | 2014-07-25 | 2014-07-29 | 1,667 | — | $0 | 61,667 | SEC↗ |
| DAVIS TRENT D | Director | A Award | 2014-07-25 | 2014-07-29 | 2,500 | — | $0 | 64,167 | SEC↗ |
| Smith Murray George | Other | A Award | 2014-07-25 | 2014-07-29 | 2,500 | — | $0 | 35,900 | SEC↗ |